An experimental treatment happens to be the solution to delay Alzheimer's symptoms in some people. These people are the ones who are genetically destined to get the disease in their 40s or 50s. These new findings form ongoing research has now been caught up in Trump administration funding delas. The early results of the study has been published on Wednesday and the participants too are worried that politics could cut their access to a possible lifeline.

One of the participants had said, "It is still a study but it has given me an extension to my life that I never banked on having." The participant is named Jake Henrichs, form New York City, who is 50 years old. He is one of them to be treated in that study for more than a decade now and has remained symptom-free despite inheriting an Alzheimer's-causing gene that had killed his father and brother around the same age.

Slowing Down The Symptoms

Two drugs which can modestly slow down early-stage Alzheimer's are sold in the United States. These drugs clear the brain of one of its hallmarks, a sticky gunk-like part called the amyloid. However, there have not been any hints that removing amyloid far earlier, way many years before the first symptoms appear, may postpone the disease.

How Was The Research Conducted?

The research is led by Washington University in St Louis, which involved families that passed down rare gene mutation as participants. This meant it was almost guaranteed that they will develop symptoms at the same age their affected relatives did.

The new findings is based on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight years. Long-term amyloid removal cut in half their risk of symptom onset. The study is published in the journal Lancet Neurology.

Washington University's Dr Randall Bateman, who directs the Dominantly Inherited Alzheimer's Network of studies involving families with these rare genes says, "What we want to determine over the next five years is how strong is the protection. Will they ever get the symptoms of Alzheimer’s disease if we keep treating them?”

The researchers before though did not know what exactly caused Alzheimer's which affects nearly 7 million Americans, most of them in their later life. However, it is clear that these silent changes occur in the brain at least two decades before the first symptom shows up. The big contributor. At some point amyloid buildup can trigger a protein named tau that then starts to kill neurons, which can lead to cognitive decline.

Researchers are now thus studying the Tau-fighting drugs and are looking into other factors, like inflammation, brain's immune cells and certain virus.

The National Institute of Health (NIH) has expanded its focus as researchers have found more reasons for Alzheimer's. In 2013, the NIH's National Institute on Aging funded 14 trials of possible Alzheimer's drugs over a third targeting amyloid. By last fall, there were 68 drugs and 18% of them target amyloid. However, there are scientists too who think that amyloid is not everything and their is way more in the brain tissue, immune cells, and more which can be studied.

Martha Lillard, the last person in the United States to rely on an iron lung for breathing, passed away, making the end of a chapter in American medical history that goes back to the devastating polio epidemics of the 20th century.

Martha Lillard’s Demise

According to her kin, Martha Lillard, 78, died on June 26, 2026, at her home in Shawnee, Oklahoma.

She had spent close to 73 years living with the effects of paralytic polio, a disease that permanently damaged the muscles needed for breathing, leaving her dependent on an iron lung, a medical device that has now become obsolete.

According to reports, chronic pulmonary failure and post-polio syndrome were listed among the causes of her death. Her family also said she experienced long COVID, which further worsened her lung function, increasing the amount of time she needed to spend inside the iron lung.

Also read: Donald Trump Says Physical Checkup At Walter Reed 'Checked Out Perfectly' Amid Recent Health Scrutiny

Martha Lillard’s Post-Polio Syndrome

Lillard contracted polio in 1953 when she was just five years old, during one of the worst outbreaks in U.S. history.

Before effective vaccines became available, the virus infected tens of thousands of Americans each year. While many people recovered, some developed paralytic polio, in which the virus attacks the nervous system, leading to paralysis and, in extreme cases, respiratory failure.

Doctors placed Lillard inside an iron lung, a large cylindrical machine that uses negative air pressure to help patients breathe by expanding and contracting the chest.

Although hospitals gradually replaced iron lungs with ventilators in the 1960s, Lillard continued using the ancient device because it proved to be the most effective method of respiratory support for her.

Her family said maintaining the iron lung became increasingly challenging as replacement parts and technicians familiar with the obsolete technology became hard to find. Still, Lillard continued using the machine well into her seventies.

Martha Lillard Refused To Let It Define Her

Despite spending most of her life inside the machine, Lillard refused to let it define her. According to her family members and previous interviews, she attended school from home through an intercom system connected to her classroom.

She also became fond of painting, writing poetry, composing music, and caring for rescued animals. She also volunteered with community organizations, including the Humane Society.

Lillard's passing comes more than 70 years after Jonas Salk's polio vaccine was introduced in 1955, followed by Albert Sabin's oral vaccine in the early 1960s. Widespread immunisation campaigns in the US significantly polio cases. The epidemic was eliminated from the country in 1979.

As one of the last survivors to depend on an iron lung, Martha Lillard's life serves as a reminder of both the devastating impact of vaccine-preventable diseases and the extraordinary developments made in public health.

At 80, Donald Trump is the oldest person to serve as president of the United States. Scrutiny surrounding his physical and cognitive health has received heightened attention in recent years, particularly following former President Joe Biden's decision to end his 2024 reelection campaign due to age and fitness.

Trump's recent post on Truth Social has sparked concerns about his health again.

Donald Trump’s Physical At Walter Reed

In a recent post, US President Donald Trump said that his latest physical examination at Walter Reed National Military Medical Center came out clean, renewing public attention on his health and wellness.

Trump wrote, “I just finished a perfect physical at Walter Reed... I do it every six months, and I requested another Cognitive Test... I aced them all. Got every question right.” He also reiterated that “everything checked out perfectly.”

After Trump's post sparked confusion over whether he had undergone a medical checkup recently, the White House clarified that he was referring to the physical examination conducted in May.

Trump's Official Medical Report

Following the May examination, White House physician Capt. Sean Barbabella released a medical memorandum stating: “President Donald Trump remains in excellent health, demonstrating strong cardiac, pulmonary, neurological, and overall physical function.”

According to the report:

• Trump scored 30 out of 30 on the Montreal Cognitive Assessment (MoCA).
• His heart scan reportedly showed no abnormalities.
• Laboratory tests and vital signs were within normal limits.
• Physicians recommended continuing preventive measures, including regular physical activity, weight management, and a low-dose aspirin regimen.

The report noted improvement in previously observed lower-leg swelling associated with chronic venous insufficiency, a condition the White House disclosed last year.

The White House attributed the visible bruises on Trump's hands to frequent handshaking while taking aspirin for cardiovascular prevention. They physician further stated that Trump is currently on medication to manage his cholesterol levels.

“The President remains up to date on all appropriate preventive screenings and immunizations,” Barbabella stated. “Routine cancer screenings, cardiovascular risk assessment, and metabolic evaluations are current and within recommended intervals. Preventive counseling was provided, including guidance on diet, recommendation to take a low-dose aspirin, increased physical activity, and continued weight loss.”

Trump’s Health Under Scrutiny

Trump's post come weeks after New York Times reporters Maggie Haberman and Jonathan Swan’s new discussed concerns raised by some aides about his age, stamina, and endurance. In the post, Trump dismissed those claims, bashing Haberman.

The president's health has also drawn scrutiny in recent months. He was recently seen with a visible neck rash and a bruised right hand that appeared to be covered with makeup during the 2026 NATO Summit in Türkiye.

Trump also appeared unsteady on his feet, particularly while using stairs. During the summit's welcome ceremony, Turkish President Recep Tayyip Erdoğan, 72, was seen taking Trump by the arm and guiding him into position.

The White House Dismissed Trump’s Health Concerns

Also read: Under HHS's 'Make Hospital Food Healthier' Pledge, Trump Administration Pushes Hospitals To Offer Healthier Food

The White House has repeatedly dismissed concerns, attributing the bruising to the physical demands of Trump's public schedule.

“President Trump is the sharpest, most accessible, and energetic president in American history,” White House spokesperson Davis Ingle said in a statement provided to The Independent. “The President is a man of the people and he meets more Americans and shakes their hands on a daily basis than any other President in history.”

The White House previously said the swelling in his legs was due to chronic venous insufficiency, a common condition affecting blood flow in the legs.

In a major regulatory move, the Centre has tightened the rules governing the sale of oral medicinal formulations with high alcohol content. The move is aimed at curbing the misuse of alcohol-containing medicines.

Medicines With Over 12% Alcohol Cannot Be Sold Over The Counter

Under the amended Drugs Rules, 1945, medicines containing more than 12% v/v ethyl alcohol and sold in quantities exceeding 30 mL can no longer be purchased over the counter and will now require a valid prescription from a registered medical practitioner.

The Ministry of Health and Family Welfare announced that these products have been removed from the exemptions provided under Schedule K of the Drugs Rules.

As a result, manufacturers and sellers must now comply with these amendments under the Drugs and Cosmetics Act, 1940, while pharmacies will be allowed to dispense these medicines only against a doctor's prescription.

The amended rules also place these formulations under Schedule H1, a category that mandates stricter controls on the sale of medicines. Pharmacies will be required to maintain detailed records of such sales, including the prescribing doctor's details and the identity of the purchaser.

Also read: Before You Take Another Paracetamol, Read This: Doctors Explain the Hidden Risks

A Step Towards Preventing Misuse

Certain oral formulations, including tinctures of cardamom, ginger and other aromatic preparations, have historically been exempt from licensing requirements despite containing alcohol levels that can reach as high as 80% to 90% by volume.

Officials said these products have increasingly been susceptible to misuse for intoxication, prompting requests from several state governments for tighter regulation.

The Health Ministry emphasized that the new rules are designed to ensure that these medicines remain available for legitimate therapeutic purposes while reducing opportunities for abuse.

By bringing them under the regulated pharmaceutical supply chain, the government expects to improve accountability from manufacturers to retailers and strengthen patient safety.

Not A Blanket Ban On All Alcohol-Containing Medicines

Importantly, the amendment does not amount to a blanket ban on alcohol-containing medicines. Products that contain 12% or less ethyl alcohol, or those packaged in quantities up to 30 mL, are not covered by the new restriction. The revised rules specifically target higher-alcohol formulations sold in larger volumes, which authorities believe carry a greater risk of misuse.

The Ministry also issued clarification about homeopathy medicines that tend to contain high amounts of alcohol. It said that homeopathy already has a similar rule in place since 1994.

Here is section: 106B. [Prohibition of quantity and percentage. [Inserted by G.S.R. 108(E), dated 22.2.1994 (w.e.f. 22.6.1994).] - No Homeopathic medicine containing more than 12% alcohol v/v (Ethyl Alcohol) shall be packed and sold in packing or bottles of more than 30 millilitres, except that it may be sold to hospitals/dispensaries in packings or bottles of not more than 100 millilitres.]

The decision is a push to promote responsible use of medicines while addressing concerns over self-medication and substance misuse.

The government maintains that these regulations will help safeguard public health without affecting access to patients who genuinely need these medicines.